From: Associations between selected immune-mediated diseases and tuberculosis: record-linkage studies
Exposure (earlier admission) | Outcome (later admission) | Observed | Expected | Rate ratio (95% CI) | Pvalue |
---|---|---|---|---|---|
Addison's disease† | Tuberculosis | 15 | 0.8 | 20.06 (11.18 to 33.27) | <0.001 |
Ankylosing spondylitis | Tuberculosis | 6 | 1.6 | 3.87 (1.42 to 8.46) | 0.002 |
Chronic active hepatitis‡ | Tuberculosis | 4 | 0.3 | 12.32 (3.35 to 31.66) | <0.001 |
Crohn's disease | Tuberculosis | 18 | 4 | 4.61 (2.72 to 7.33) | <0.001 |
Pernicious anemia | Tuberculosis | 25 | 11.1 | 2.28 (1.47 to 3.39) | <0.001 |
Rheumatoid arthritis | Tuberculosis | 69 | 26.7 | 2.71 (2.09 to 3.46) | <0.001 |
SLEb | Tuberculosis | 8 | 0.5 | 17.29 (7.44 to 34.22) | <0.001 |
Tuberculosis | Addison's diseaseb | 13 | 1.9 | 7.6 (3.94 to 13.48) | <0.001 |
Tuberculosis | Chronic active hepatitisc | 6 | 1.2 | 5.37 (1.93 to 12.07) | <0.001 |
Tuberculosis | Goodpasture's syndromeb | 2 | 0.3 | 8.09 (0.91 to 34.08) | 0.018 |
Tuberculosis | Myxedemab | 36 | 23.1 | 1.57 (1.1 to 2.18) | 0.009 |
Tuberculosis | SLEb | 7 | 1.4 | 5.31 (2.1 to 11.21) | <0.001 |
Tuberculosis | Dermatomyositisb | 3 | 0.4 | 8.18 (1.6 to 26.15) | 0.001 |